Clinical Laserthermia Systems
Clinical Laserthermia Systems (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods, for heat-induced immunotherapy enabling safe and gentle treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for CLS’ own immunostimulating therapy, imILT®. The company is headquartered in Lund, Sweden, with subsidiaries in Berlin, Germany and in Boston, USA. CLS is listed on Nasdaq First North under the stock symbol CLS B.
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Clinical Laserthermia Systems use?+
Clinical Laserthermia Systems uses 21 technologies including Bootstrap, Elementor, Font Awesome.
What industry is Clinical Laserthermia Systems in?+
Clinical Laserthermia Systems operates in the Biotechnology industry.
Where is Clinical Laserthermia Systems based?+
Clinical Laserthermia Systems is headquartered in Sweden.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026